Third Death In Audentes’ XLMTM Gene Therapy Trial

But Companies Remain 'Committed'

 
• By Ian Haydock
  
Gene therapy in bottle and syringe for injection. Gene therapy or gene transfer used for treatment or prevention disease as cancer, cystic fibrosis. Medical genetic and research technology concept.
Third Death In XLMTM Trial • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D